Literature DB >> 1333449

Rickettsia rickettsii induces superoxide radical and superoxide dismutase in human endothelial cells.

L A Santucci1, P L Gutierrez, D J Silverman.   

Abstract

Human endothelial cells infected with Rickettsia rickettsii, the etiological agent of Rocky Mountain spotted fever, undergo striking morphological changes to the endoplasmic reticulum-outer nuclear envelope complex. These changes are accompanied by concurrent accumulation of intracellular peroxides. Both of these findings are consistent with the notion that cells undergo some form of oxidative stress. Since oxidant injury is often initiated or mediated through oxygen radicals, we examined superoxide radical generation when endothelial cells were exposed to R. rickettsii. We also examined the levels of superoxide dismutase, an enzyme induced in response to increased superoxide formation. The levels of both superoxide and superoxide dismutase increased when endothelial cells were exposed to R. rickettsii. These results, together with our previous findings, support our hypothesis that cells infected by this intracellular bacterium experience oxidant-mediated injury that may eventually contribute to cell death.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333449      PMCID: PMC258285          DOI: 10.1128/iai.60.12.5113-5118.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  In vitro studies of rickettsia-host cell interactions: ultrastructural changes induced by Rickettsia rickettsii infection of chicken embryo fibroblasts.

Authors:  D J Silverman; C L Wisseman
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  STAINING RICKETTSIAE IN YOLK-SAC CULTURES.

Authors:  D F GIMENEZ
Journal:  Stain Technol       Date:  1964-05

3.  A potential protective role for thiols against cell injury caused by Rickettsia rickettsii.

Authors:  D J Silverman; L A Santucci
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical.

Authors:  C C Winterbourn; A Stern
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

Review 5.  Culture of vascular endothelium.

Authors:  M A Gimbrone
Journal:  Prog Hemost Thromb       Date:  1976

6.  Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation.

Authors:  D C Salo; R E Pacifici; S W Lin; C Giulivi; K J Davies
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

7.  Penetration of cultured mouse fibroblasts (L cells) by Rickettsia prowazeki.

Authors:  T S Walker; H H Winkler
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

8.  Endothelial cells: a source and target of oxidant damage.

Authors:  U S Ryan; J M Vann
Journal:  Basic Life Sci       Date:  1988

9.  Infection cycle of Rickettsia rickettsii in chicken embryo and L-929 cells in culture.

Authors:  C L Wisseman; E A Edlinger; A D Waddell; M R Jones
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

10.  Superoxide dismutase is preferentially degraded by a proteolytic system from red blood cells following oxidative modification by hydrogen peroxide.

Authors:  D C Salo; S W Lin; R E Pacifici; K J Davies
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

View more
  24 in total

1.  Rickettsia rickettsii infection of cultured human endothelial cells induces heme oxygenase 1 expression.

Authors:  Elena Rydkina; Abha Sahni; David J Silverman; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Similar compositional biases are caused by very different mutational effects.

Authors:  Eduardo P C Rocha; Marie Touchon; Edward J Feil
Journal:  Genome Res       Date:  2006-10-26       Impact factor: 9.043

3.  Superoxide dismutase-dependent, catalase-sensitive peroxides in human endothelial cells infected by Rickettsia rickettsii.

Authors:  J E Hong; L A Santucci; X Tian; D J Silverman
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection.

Authors:  D R Clifton; R A Goss; S K Sahni; D van Antwerp; R B Baggs; V J Marder; D J Silverman; L A Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

5.  Rickettsia rickettsii infection of human macrovascular and microvascular endothelial cells reveals activation of both common and cell type-specific host response mechanisms.

Authors:  Elena Rydkina; Loel C Turpin; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

6.  Effects of the antioxidant alpha-lipoic acid on human umbilical vein endothelial cells infected with Rickettsia rickettsii.

Authors:  M E Eremeeva; D J Silverman
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii.

Authors:  S K Sahni; D J Van Antwerp; M E Eremeeva; D J Silverman; V J Marder; L A Sporn
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 8.  Infection of the endothelium by members of the order Rickettsiales.

Authors:  Gustavo Valbuena; David H Walker
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

9.  Molecular cloning, characterization, and expression in Escherichia coli of iron superoxide dismutase cDNA from Leishmania donovani chagasi.

Authors:  S O Ismail; Y A Skeiky; A Bhatia; L A Omara-Opyene; L Gedamu
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Interferon-gamma and tumor necrosis factor-alpha exert their antirickettsial effect via induction of synthesis of nitric oxide.

Authors:  H M Feng; D H Walker
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.